Excluding one-time items, earnings are projected to range from $3.28 to $3.38 a share.
Room prices at the Hampton hotels in Chelsea, Herald Square and on Pearl Street are projected to range from $160 to $225.
The annual cost savings resulting from the introduction of Remsima were projected to range from €2.89 million (Belgium, 10% discount) to €33.80 million (Germany, 30% discount).
The cumulative drug cost savings across the five countries included (Germany, the UK, Italy, the Netherlands, and Belgium) and the six licensed disease areas were projected to range from €25.79 million (10% discount) to €77.37 million (30% discount).
The cumulative cost savings across the five included countries and the six licensed disease areas were projected to range from €25.79 million (10% discount) to €77.37 million (30% discount).
Climate change is projected to expand the range of suitable habitat for the organisms that cause ciguatera by expanding the range of warm SSTs and bleaching coral reefs (Moore et al. 2008).
Meanwhile, warming is projected to expand the range of ticks that carry Lyme disease as well as malaria-bearing mosquitoes and is projected to do so even more in a warmer regime.
In terms of guidance, revenue for the first quarter of 2012 is projected to be in the range of $170 million to $175 million and revenue for the full year will be in the range of $840 million to $860 million.
